Your search for oral corticosteroids returned 20 results

Your search for oral corticosteroids returned 20 results

Sort Results:

Relevant Recent

ATS 2021, News

Oral Corticosteroid Dose Management With Impaired Adrenal Function Evaluated

Publish Date May 14, 2021

Patients with normal adrenal function are largely able to eliminate the use of oral corticosteroids or achieve a daily dose of 5 mg or less.

News

Drug-Induced Immunosuppression Examined in US Adults

Publish Date June 3, 2021

Drug-induced immunosuppression, particularly from oral corticosteroids, may limit response to COVID-19 vaccine

AAAAI 2021, News

Benralizumab May Reduce or Eliminate Oral Corticosteroid Use in Severe Asthma

Publish Date March 1, 2021

Patients with asthma who depend on oral corticosteroids (OCS) may be able to reduce the dependence or eliminate the use of OCS altogether with benralizumab.

CHEST 2021, News

Dupilumab Improves Severe Asthma Outcomes, Regardless of Baseline OCS Dose

Publish Date October 18, 2021

A post-hoc analysis of the VENTURE trial evaluated whether baseline oral corticosteroid dosage affected the efficacy of dupilumab in improving severe asthma outcomes.

ATS 2021, News

Dupilumab Effective in Treating OCS-Dependent Asthma, Weaning OCS Use

Publish Date May 18, 2021

Long-term treatment of oral corticosteroid (OCS)-dependent asthma with dupilumab has shown efficacy in weaning off OCS while improving lung function.

Drugs in the Pipeline, News

FDA Grants Fast Track Designation to Orismilast for Atopic Dermatitis

Publish Date November 4, 2021

The FDA's Fast Track process allows for expedited review of drugs that are expected to fill an unmet need.

News

Zolgensma Labeling Updated With Additional Safety Information

Publish Date October 27, 2021

Zolgensma is an adeno-associated virus vector-based gene therapy.

Drugs in the Pipeline

Dupilumab Under Review for Pediatric Asthma

Publish Date March 4, 2021

The submission was based on data from the double-blind, placebo-controlled VOYAGE trial.

AAO-HNS 2021

Corticosteroid Responsiveness Assessed in Patients with Chronic Cough

Publish Date October 4, 2021

The most common presenting complaints included shortness of breath, rhinorrhea, and hoarseness.

Drugs in the Pipeline

Tezepelumab BLA Submitted for Severe Asthma

Publish Date May 10, 2021

The BLA submission is supported by data from the PATHFINDER clinical program.